SALVATORE J ZIZZA
CIK 929743 · Chief Exectuive Officer · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$329.8K
Companies
10
Total Filings
70
Lifetime Open-Market Net
$817.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GDV | Director | 3,086 | $30.00 | $92.6K | $14.3K | 3 | 2026-07-01 |
| GUT | Director | 13,090 | $6.40 | $83.8K | $99.7K | 10 | 2024-10-25 |
| GGT | Director | 11,037 | $4.04 | $44.6K | $96.7K | 9 | 2024-07-25 |
| GCV | Director | 0 | $4.53 | $0 | $379.2K | 5 | 2023-12-28 |
| GAB | Director | 16,466 | $5.65 | $93.0K | -$8.7K | 8 | 2021-07-23 |
| GGN | Director | 0 | $4.84 | $0 | $196.2K | 5 | 2018-12-31 |
| GRX | Director | 1,165 | $9.79 | $11.4K | $9.5K | 7 | 2018-12-31 |
| GGZ | Director | 150 | $16.03 | $2.4K | $0 | 1 | 2017-12-14 |
| JOB | Chief Exectuive Officer | 9,720 | $0.21 | $2.0K | $30.8K | 9 | 2011-12-23 |
| Harbor BioSciences, Inc. (HEPH) Delisted | Director | — | — | — | $0 | 3 | 2010-02-03 |
Recent Filings · Page 7 of 7
70 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-04-01 | GCV | Sell (S) | −24,129 | -$146.0K | EDGAR |
| 2010-02-03 | Harbor BioSciences, Inc. (HEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-01-09 | — | Mixed | — | $0 | |
| 2008-06-26 | — | Other (J) | — | $0 | |
| 2008-06-02 | — | Buy (P) | +1,000 | $29.0K | |
| 2008-04-24 | — | Other (J) | +699 | $0 | |
| 2008-01-29 | Harbor BioSciences, Inc. (HEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-01-22 | Harbor BioSciences, Inc. (HEPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-02 | GRX | Other (J) | +1,709 | $0 | EDGAR |
| 2007-04-03 | — | Buy (P) | — | $0 |
Showing 61–70 of 70
Prev
Page 7 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.